Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...

Young people are being made aware of a type of cancer called Hodgkin lymphoma, which predominantly affects adults in their ...

An investigational therapy is demonstrating preclinical promise against non-Hodgkin lymphoma by boosting natural killer cells ...

Dr Sehn and colleagues evaluated the combination in the phase 3 inMIND trial (NCT04680052), which included 548 adults with grade 1-3A follicular lymphoma. The patients’ median age at baseline was 64 ...

In addition to the progression-free survival primary endpoint, the tafasitamab arm also had a higher rate of complete ...